Venlafaxine ER 225mg Tablets

Manufacturer TRIGEN Active Ingredient Venlafaxine Extended-Release Tablets(ven la FAX een) Pronunciation ven la FAX een
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidepressant
🧬
Pharmacologic Class
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
🀰
Pregnancy Category
Category C (Note: FDA now uses risk summaries, but historically C)
βœ…
FDA Approved
Sep 1997
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Venlafaxine ER is an antidepressant medication that works by affecting certain natural chemicals in the brain (serotonin and norepinephrine) that help regulate mood. It's used to treat depression, anxiety disorders, and panic disorder. The 'ER' means extended-release, so it's designed to release the medicine slowly over time, allowing for once-daily dosing.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication with food to help your body absorb it properly.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

Important Administration Instructions

Swallow your medication whole - do not chew, break, or crush it.
Take your medication with a full glass of water.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom.
Keep all medications in a safe and secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. Check with your pharmacist for guidance on the best way to dispose of your medication, and consider participating in a drug take-back program in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
If it is close to the time for your next dose, skip the missed dose and resume your regular schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Take the tablet whole; do not crush, chew, or divide it. It can be taken with food.
  • Take at approximately the same time each day.
  • Avoid alcohol, as it can increase side effects.
  • Be cautious when driving or operating machinery until you know how the medication affects you, as it can cause dizziness or drowsiness.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking, especially St. John's Wort, triptans, or other antidepressants.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: For Major Depressive Disorder (MDD): Initial 37.5 mg or 75 mg extended-release once daily. Titrate by 75 mg/day increments every 4-7 days. Usual therapeutic dose is 75-225 mg/day. Max 225 mg/day for MDD.
Dose Range: 37.5 - 225 mg

Condition-Specific Dosing:

Generalized Anxiety Disorder (GAD): Initial 75 mg extended-release once daily. Max 225 mg/day.
Social Anxiety Disorder (SAD): Initial 75 mg extended-release once daily. Max 225 mg/day.
Panic Disorder (PD): Initial 37.5 mg extended-release once daily for 7 days, then increase to 75 mg once daily. Max 225 mg/day.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established for MDD in pediatric patients <18 years old. Use generally not recommended due to increased risk of suicidal thoughts and behaviors.)
Adolescent: Not established (Safety and efficacy not established for MDD in pediatric patients <18 years old. Use generally not recommended due to increased risk of suicidal thoughts and behaviors.)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: CrCl 30-60 mL/min: Reduce total daily dose by 25-50%.
Moderate: CrCl <30 mL/min: Reduce total daily dose by 50%.
Severe: CrCl <30 mL/min: Reduce total daily dose by 50%.
Dialysis: Reduce total daily dose by 50%. Administer after dialysis session.

Hepatic Impairment:

Mild: Not specified, generally no adjustment needed.
Moderate: Child-Pugh B: Reduce total daily dose by 50%.
Severe: Child-Pugh C: Reduce total daily dose by 50% or more.

Pharmacology

πŸ”¬

Mechanism of Action

Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and a weak inhibitor of dopamine reuptake. This leads to an increase in the synaptic concentrations of these neurotransmitters in the central nervous system, which is thought to mediate its antidepressant and anxiolytic effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 45% (venlafaxine), ~92% (ODV)
Tmax: Venlafaxine ER: 5.5 hours; ODV: 9 hours
FoodEffect: Food delays Tmax by 2-3 hours but does not significantly affect AUC or Cmax of venlafaxine or ODV.

Distribution:

Vd: Venlafaxine: Approximately 7.5 L/kg
ProteinBinding: Venlafaxine: Approximately 27%; ODV: Approximately 30%
CnssPenetration: Yes

Elimination:

HalfLife: Venlafaxine: Approximately 5 hours; ODV: Approximately 11 hours
Clearance: Venlafaxine: 1.3 Β± 0.6 L/h/kg; ODV: 0.4 Β± 0.2 L/h/kg
ExcretionRoute: Primarily renal (approximately 87% of a dose is excreted in the urine within 48 hours as unchanged venlafaxine, unconjugated ODV, or conjugated ODV)
Unchanged: Approximately 5% (venlafaxine)
⏱️

Pharmacodynamics

OnsetOfAction: Initial effects (e.g., improved sleep, appetite) may be seen within 1-2 weeks; full antidepressant effects may take 4-6 weeks or longer.
PeakEffect: Typically 4-6 weeks for full therapeutic effect.
DurationOfAction: Once daily dosing due to extended-release formulation and active metabolite half-life.

Safety & Warnings

⚠️

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of venlafaxine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Venlafaxine is not approved for use in pediatric patients.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Difficulty focusing
+ Memory problems
+ Confusion
+ Weakness
+ Seizures
+ Changes in balance
Signs of bleeding, such as:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Fainting or loss of consciousness
+ Changes in vision
Seizures
Chest pain or pressure
Shortness of breath
Cough
Bone pain
Sex problems, such as:
+ Decreased interest in sex
+ Difficulty having an orgasm
+ Ejaculation problems
+ Trouble getting or maintaining an erection
A potentially life-threatening condition called serotonin syndrome, which may be more likely if you take certain other medications. Symptoms include:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Rapid or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, stomach upset, or vomiting
+ Severe headache

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people experience no side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Trouble sleeping
Feeling nervous or excitable
Anxiety
Weight loss
Dizziness, drowsiness, tiredness, or weakness
Shakiness
Headache
Excessive sweating
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Gas
Dry mouth
Strange or unusual dreams
* Yawning

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or suicidal thoughts, especially at the beginning of treatment or after a dose change.
  • Symptoms of serotonin syndrome: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea.
  • New or worsening high blood pressure.
  • Eye pain, changes in vision, or swelling or redness in or around the eye (signs of angle-closure glaucoma).
  • Unusual bleeding or bruising.
  • Seizures.
  • Symptoms of hyponatremia (low sodium): headache, confusion, weakness, unsteadiness, muscle cramps, seizures.
πŸ“‹

Before Using This Medicine

Before taking this medication, it is essential to inform your doctor about the following:

Any allergies you have, including allergies to this drug, its components, or other substances, such as foods or medications. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have high blood pressure, as this medication may affect your condition.
If you have narrow-angle glaucoma, a condition that affects the pressure in your eyes.
If you are taking a weight loss drug, as this may interact with the medication.
If you are taking certain medications, such as Linezolid or methylene blue, as these can cause serious interactions.
If you have taken specific medications for depression or Parkinson's disease within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline. Taking these medications with this drug can lead to very high blood pressure.

It is crucial to note that this is not an exhaustive list of all potential interactions or health problems that may affect the safety of this medication. Therefore, it is vital to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have. This will help ensure that it is safe for you to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you.

To minimize the risk of severe side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue use, your doctor will provide guidance on how to gradually stop taking it. Be sure to discuss any new or worsening symptoms with your doctor.

Regular blood pressure checks are crucial while taking this medication, as it may cause high blood pressure. Your doctor will advise you on the frequency of these checks.

It is recommended to avoid consuming alcohol while taking this medication. Additionally, consult your doctor before using marijuana, cannabis, or prescription or over-the-counter drugs that may cause drowsiness.

This medication may increase the risk of bleeding, which can be life-threatening in some cases. Discuss this risk with your doctor.

If you have bipolar disorder, be aware that this medication may trigger manic episodes. Immediately contact your doctor if you experience symptoms of a manic episode.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess this risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor promptly.

Low blood sodium levels, which can be fatal in severe cases, may occur with this medication. Discuss this risk with your doctor.

High cholesterol has been associated with this medication. If you have concerns, consult your doctor.

This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

You may notice the tablet shell in your stool, but this is normal and not a cause for concern.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

In some cases, this medication may affect growth in children and adolescents. Regular growth checks may be necessary, and your doctor will discuss this with you.

If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the benefits and risks of taking this medication. Taking this medication in mid to late pregnancy may lead to health problems in the mother, such as postpartum bleeding, or the newborn. Your doctor will help you weigh the risks and benefits.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Somnolence
  • Mild tachycardia
  • Mydriasis
  • Nausea
  • Vomiting
  • Dizziness
  • ECG changes (e.g., QT prolongation, bundle branch block, QRS prolongation)
  • Bradycardia
  • Hypotension
  • Seizures
  • Vertigo
  • Serotonin syndrome
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is generally supportive and symptomatic. Ensure adequate airway, oxygenation, and ventilation. Activated charcoal may be considered if ingested recently. Monitor cardiac rhythm and vital signs.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (risk of serious, sometimes fatal, serotonin syndrome; allow at least 14 days between discontinuing MAOI and starting venlafaxine, and at least 7 days between discontinuing venlafaxine and starting MAOI)
  • Linezolid (reversible non-selective MAOI)
  • Methylene Blue (reversible non-selective MAOI)
πŸ”΄

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, other SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, St. John's Wort, amphetamines) - increased risk of serotonin syndrome.
  • Drugs that impair metabolism of venlafaxine (e.g., strong CYP2D6 inhibitors like quinidine, fluoxetine, paroxetine) - may increase venlafaxine levels and decrease ODV levels.
  • Warfarin - increased risk of bleeding.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, antipsychotics, macrolide antibiotics) - theoretical risk of QT prolongation, though venlafaxine itself has minimal effect.
🟑

Moderate Interactions

  • Alcohol - may enhance CNS effects and impair psychomotor performance.
  • Cimetidine - may inhibit first-pass metabolism of venlafaxine, increasing AUC.
  • Haloperidol - increased haloperidol AUC and Cmax.
  • Indinavir - decreased indinavir AUC and Cmax.
  • Ketoconazole - increased venlafaxine and ODV AUC in poor CYP2D6 metabolizers.
🟒

Minor Interactions

  • Not typically categorized as minor for venlafaxine, most interactions are moderate to major due to serotonin syndrome risk or pharmacokinetic changes.

Monitoring

πŸ”¬

Baseline Monitoring

Blood Pressure (BP) and Heart Rate (HR)

Rationale: Venlafaxine can cause dose-dependent increases in BP and HR.

Timing: Prior to initiation

Weight

Rationale: Monitor for significant weight changes (gain or loss).

Timing: Prior to initiation

Mental Status/Suicidality

Rationale: Assess baseline mood, anxiety, and suicidal ideation, especially in young adults.

Timing: Prior to initiation

Electrolytes (Sodium)

Rationale: Risk of hyponatremia, especially in elderly or those on diuretics.

Timing: Prior to initiation (consider in at-risk patients)

πŸ“Š

Routine Monitoring

Blood Pressure (BP) and Heart Rate (HR)

Frequency: Regularly, especially during dose titration and periodically thereafter.

Target: Maintain within normal limits or patient's baseline.

Action Threshold: Sustained hypertension (e.g., >140/90 mmHg) or significant tachycardia; consider dose reduction or alternative treatment.

Mental Status/Suicidality

Frequency: Weekly during initial weeks of therapy and dose changes, then periodically.

Target: Improvement in mood/anxiety, absence of suicidal ideation.

Action Threshold: Worsening depression, emergence of suicidal thoughts/behavior, agitation, mania; immediate clinical reassessment.

Weight

Frequency: Periodically.

Target: Stable weight.

Action Threshold: Significant, unexplained weight gain or loss.

Electrolytes (Sodium)

Frequency: Periodically, especially in elderly or those on diuretics.

Target: Normal serum sodium (135-145 mEq/L).

Action Threshold: Hyponatremia (<135 mEq/L); investigate cause, consider dose reduction or discontinuation.

Adverse Effects

Frequency: Regularly, especially during initial weeks and dose changes.

Target: Tolerable side effect profile.

Action Threshold: Intolerable side effects (e.g., severe nausea, dizziness, sweating, sexual dysfunction); consider dose adjustment or alternative.

πŸ‘οΈ

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior (especially in young adults)
  • Unusual changes in behavior (e.g., agitation, irritability, aggression, panic attacks, insomnia, impulsivity, akathisia, hypomania, mania)
  • Symptoms of serotonin syndrome (e.g., agitation, hallucinations, rapid heart rate, fever, sweating, shivering, muscle rigidity, twitching, incoordination, nausea, vomiting, diarrhea)
  • Symptoms of withdrawal syndrome (e.g., dizziness, headache, nausea, insomnia, irritability, anxiety, electric shock-like sensations) upon abrupt discontinuation
  • New or worsening hypertension
  • New or worsening anxiety

Special Patient Groups

🀰

Pregnancy

Use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Exposure during late pregnancy may lead to complications in the neonate requiring prolonged hospitalization, respiratory support, and tube feeding.

Trimester-Specific Risks:

First Trimester: Limited data, but some studies suggest a possible increased risk of certain birth defects (e.g., cardiac anomalies) with first-trimester exposure to SNRIs/SSRIs, though overall risk is low and inconsistent across studies.
Second Trimester: Not well-studied for specific risks.
Third Trimester: Risk of persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypotonia, constant crying) if exposed late in the third trimester.
🀱

Lactation

Venlafaxine and its active metabolite (ODV) are excreted into human milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the mother’s clinical need for venlafaxine, and any potential adverse effects on the breastfed infant from venlafaxine or from the underlying maternal condition.

Infant Risk: L3 (Moderate risk). Monitor breastfed infants for sedation, poor feeding, poor weight gain, and irritability. Some case reports of adverse effects in infants, but many infants show no adverse effects.
πŸ‘Ά

Pediatric Use

Not approved for use in pediatric patients for MDD due to increased risk of suicidal thoughts and behaviors. Safety and efficacy have not been established. Use in children and adolescents should be carefully weighed against the risks, and patients should be closely monitored.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness were observed between geriatric and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Elderly patients may be at increased risk for hyponatremia and falls. Dose adjustments may be necessary due to age-related decreases in renal and hepatic function.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Venlafaxine ER capsules contain spheroids that release the drug slowly. Patients may notice these 'ghost tablets' in their stool, which is normal and does not mean the medication was not absorbed.
  • Abrupt discontinuation or significant dose reduction can lead to severe withdrawal symptoms (e.g., dizziness, nausea, headache, 'brain zaps', anxiety, insomnia). Taper slowly over several weeks, especially after prolonged use.
  • Monitor blood pressure regularly, as venlafaxine can cause dose-dependent hypertension, particularly at higher doses.
  • Consider venlafaxine for patients who have not responded to SSRIs, as its dual mechanism (serotonin and norepinephrine reuptake inhibition) may be more effective for some individuals.
  • Take with food to minimize gastrointestinal upset.
πŸ”„

Alternative Therapies

  • Other SNRIs (e.g., Duloxetine, Desvenlafaxine, Levomilnacipran)
  • SSRIs (e.g., Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram)
  • Atypical antidepressants (e.g., Bupropion, Mirtazapine)
  • Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline, Nortriptyline)
  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., Phenelzine, Tranylcypromine, Selegiline - generally reserved for refractory cases)
πŸ’°

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (generic 225mg ER)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.